'We founded IXICO to bring the best possible image analysis technology and know-how to the pharmaceutical and medical device industries. Working with our customers, we can unlock imaging's potential to accelerate and reduce the costs of product development, and hence give more patients earlier access to effective and safe treatments.'
Prof Derek Hill, IXICO's CEO
IXICO Ltd. was formed in 2004 using technology from some of the most prestigious academic institutions in the UK with the goal of providing the best possible imaging solutions to the pharmaceutical industry. In particular, to:
- Accelerate product development bringing patients earlier access to safe and effective treatments.
- Increasing sensitivity to precisely quantify treatment effects and therefore enable better decision making throughout the drug development pipeline.
- Reduce costs through use of smaller cohorts and shorter trial duration.
Latest news updates
ADDED 16 OCT 2007
IXICO to present @ Alzheimer's Drug Development Summit, 29-30 Nov. 2007, Arlington, VA, US
Dr. David Cash, Senior Scientist will be presenting "Challenges in Multi-Center Deployment of Structural MRI Biomarkers"
ADDED 16 OCT 2007
IXICO to present @ Anti-Arthritic Agents Conference, 19-20 Nov. 2007, London, UK
Dr. Stephen Oakley, IXICO's Clinical advisor, will be presenting, "MRI Assessment of Rheumatoid Arthritis" during Anti-Arthritic Agents Conference
